Eravacycline Dihydrochloride

Records for this ingredient, by country (identity only).

ATC — · 2 markets · 3 records

Eravacycline Dihydrochloride 2 markets · 3 records Forms
Filters
MarketUS 2SG 1

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

  • 100 mg per mL / per unit basis not statedinjectionXerava
  • 50 mg per mL / per unit basis not statedinjectionXerava

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 50 mg/vial per mL / per unit basis not statedinjectionXERAVA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG PER VIAL

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.